Stock 2616 CSTONE PHARMACEUTICALS
Add to a list
To use this feature you must be a member
Log inSign up

Insiders CStone Pharmaceuticals

Equities

2616

KYG2588M1006

Market Closed - Hong Kong S.E.
Other stock markets
 01:38:42 28/06/2024 pm IST 		5-day change 1st Jan Change
1.14 HKD +2.70% Intraday chart for CStone Pharmaceuticals +4.59% -49.78%
18/06 CStone Pharmaceuticals Announces Change of Joint Company Secretary CI
13/06 CStone Gets Green Light for Local Manufacturing of AYVAKIT in China MT

Insiders

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CStone Pharmaceuticals Announces Change of Joint Company Secretary
CI
Non-Executive Director Increases Shareholding in CStone Pharma; Shares Surge 25%
MT
Cstone Pharmaceuticals’ CEO Boosts Stakeholding
MT
Cstone Pharmaceuticals Announces Management Changes
CI
CStone Pharmaceuticals Announces Board and Executive Changes
CI
CStone Pharmaceuticals Announces CEO Changes
CI
CStone Pharmaceuticals Announces Executive Changes
CI
Transcenta Hires Former CStone Pharma Exec as CFO
MT
Cstone Pharmaceuticals Announces Executive Changes
CI
CStone Pharmaceuticals Announces Company Secretary Changes, Effective 25 January 2021
CI
CStone Pharmaceuticals Appoints Shirley Zhao as General Manager for Greater China and Head of Commercial
CI
CStone Pharmaceuticals Announces Board and Nomination Committee Changes
CI
CStone Pharmaceuticals Appoints Scientific Advisory Board Members
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2616 Stock
  4. News CStone Pharmaceuticals
  5. Insiders